David Swartz is a seasoned professional in the IVD diagnostic and precision medicine industry with over 20 years of experience. Currently serving as the Global Oncology Diagnostics Director at AstraZeneca, David has also held key roles at prominent companies such as Bayer Healthcare, AstraZeneca, and Fujirebio US. With expertise in gene expression, molecular diagnostics, and immunoassay techniques, David excels in strategic planning, product development, and market research. David's educational background includes a Bachelor of Arts from the University of Oregon and Executive Education in Marketing from The Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices